P980053/S021: Durasphere Injectable Bulking Agent
FDA’s recorded scope: a change to the syringe cap of the 1 mL Durasphere device configuration
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Carbon Medical Technologies, Inc.. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 13, 2026 to Mar 31, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code FBK appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P980053, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 1290 Hammond Rd., St. Paul, MN, 55110, US. Recorded on K253598, decision dated Mar 31, 2026.
Endoscopic Injection Needle, Gastroenterology-Urology; AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE.
FDA’s recorded scope: a change to the syringe cap of the 1 mL Durasphere device configuration
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.